Do Clinical Outcomes in Chronic Hemodialysis Depend on the Choice of a Dialyzer?

Seminars in Dialysis

Volumn 24, Issue 1, 2011, Pages 65-71

  Ward, Richard A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ARTICLE; ARTIFICIAL MEMBRANE; CHRONIC KIDNEY FAILURE; EQUIPMENT DESIGN; HUMAN; METHODOLOGY; RENAL REPLACEMENT THERAPY;

DIALYSIS SOLUTIONS; EQUIPMENT DESIGN; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 79951796348     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00807.x     Document Type: Article

References (54)

1. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
2. Ronco C, Ghezzi PM, Bowry SK: Membranes for hemodialysis. In: Hörl WH, Koch KM, Lindsay RM, Ronco C, Winchester JF (eds). Replacement of Renal Function by Dialysis, 5th ed. Dordrecht: Kluwer Academic, 2004: 301-323
3. Ward RA: Phagocytic cell function as an index of biocompatibility. Nephrol Dial Transplant 9(Suppl 2):46-56, 1994
4. Lonnemann G, Behme TC, Lenzner B, Floege J, Schulze M, Colton CK, Koch KM, Shaldon S: Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 42:61-68, 1992
5. Schindler R, Beck W, Deppisch R, Aussieker M, Wilde A, Göhl H, Frei U: Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol 15:3207-3214, 2004
6. Lonnemann G, Sereni L, Lemke H-D, Tetta C: Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. Artif Organs 25:951-960, 2001
7. Ansorge W, Pelger M, Dietrich W, Baurmeister U: Ethylene oxide in dialyzer rinsing fluid: effect of rinsing technique, dialyzer storage time, and potting compound. Artif Organs 11:118-122, 1987
8. 2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant. DOI: 10.1093/ndt/gfq326 [Epub ahead of print]
9. Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs 12:387-392, 1966
10. oA and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO J 50:85-93, 2004
11. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
12. Ledebo I, Blankestijn PJ: Haemodiafiltration - optimal efficiency and safety. NDT Plus 3:8-16, 2010
13. Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G: Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer. Kidney Int 54:979-985, 1998
14. Tomo T, Matsuyama M, Nakata T, Kadota J-I, Toma S, Koga N, Fukui H, Arizono K, Takamiya T, Matsuyama K, Ueyama S, Shiohira Y, Uezu Y, Higa A: Effect of high fiber density ratio polysulfone dialyzer on protein removal. Blood Purif 26:347-353, 2008
15. Ronco C, Brendolan A, Lupi A, Metry G, Levin NW: Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58:809-817, 2000
16. Miller JH, von Albertini B, Gardner PW, Shinaberger JH: Technical aspects of high-flux hemodiafiltration for adequate short (under 2hours) treatment. Trans Am Soc Artif Intern Organs 30:377-381, 1984
17. Ouseph R, Hutchison CA, Ward RA: Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers. Nephrol Dial Transplant 23:1704-1712, 2008
18. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3:1227-1237, 1992
19. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L: Effect of dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50:566-570, 1996
20. Koda Y, Nishi S-I, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52:1096-1101, 1997
21. Bloembergen WE, Hakim RM, Stannard DC, Held PJ, Wolfe RA, Agodoa LYC, Port FK: Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33:1-10, 1999
22. Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A: Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in Japanese patients on chronic non-reuse hemodialysis: a prospective cohort study form the J-DOPPS II study. Nephron Clin Pract 109:c100-c108, 2008
23. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 50:1293-1302, 1996
24. Krane V, Krieter DH, Olschewski M, März W, Mann JFE, Ritz E, Wanner C: Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49:267-275, 2007
25. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 39:320-327, 1991
26. Parker TF, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49:551-556, 1996
27. Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 40:714-719, 1991
28. MacLeod AM, Campbell MK, Cody JD, Daly C, Grant A, Khan I, Rabindranath KS, Vale L, Wallace SA: Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Cochrane Database Syst Rev 2005, 3. Art. No.: CD003234. DOI.
29. Marshall CP, Pearson FC, Sagona MA, Lee W, Wathen RL, Ward RA, Dolovich J: Reactions during hemodialysis caused by allergy to ethylene oxide gas sterilization. J Allergy Clin Immunol 75:563-567, 1985
30. Lemke HD, Heidland A, Schaefer RM: Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies. Nephrol Dial Transplant 5:264-269, 1990
31. Krieter DH, Grude M, Lemke H-D, Fink E, Bönner G, Schölkens BA, Schulz E, Müller GA: Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int 53:1026-1035, 1998
32. Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A: The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 29:1139-1146, 2008
33. Huang W-H, Lee Y-Y, Shih L-C: Delayed near-fatal anaphylactic reaction induced by the F10-HPS polysulfone haemodialyser. Nephrol Dial Transplant 23:423-424, 2008
34. Post JB: Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis 55:e25-e28, 2010
35. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Dialysis Study. N Engl J Med 305:1176-1181, 1981
36. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985
37. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
38. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Measurement of dialyzer clearance, dialysis time, and body size: death risk relationship among patients. Kidney Int 66:2077-2084, 2004
39. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48(Suppl 1):S2-S90, 2006
40. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G: Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 65:1386-1394, 2004
41. Daugirdas JT, Greene T, Chertow GM, Depner TA: Can rescaling dose of dialysis to body surface area in the HEMO Study explain the different responses to dose in women versus men? Clin J Am Soc Nephrol 5:1628-1636, 2010
42. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, Port FK: Effect of dialysis membrane and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 33:349-355, 1999
43. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J: A bench to bedside view of uremic toxins. J Am Soc Nephrol 19:863-870, 2008
44. Woods HF, Nandakumar M: Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 15(Suppl 1):36-42, 2000
45. Locatelli F, Martin-Melo A, Hannedouche T, Loureiro A, Papadimitriou V, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R: Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20:645-654, 2009
46. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO Study. J Am Soc Nephrol 14:3251-3263, 2003
47. 2-microglobulin levels predict mortality in dialysis patients: Results of the HEMO Study. J Am Soc Nephrol 17:546-555, 2006
48. 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 3:69-77, 2008
49. 2-microglobulin. J Am Soc Nephrol 10:117-127, 1999
50. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69:2087-2093, 2006
51. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K: Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 4:1944-1953, 2009
52. Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GFM: The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 52:507-518, 2008
53. Blankestijn PJ, Ledebo I, Canaud B: Hemodiafiltration: clinical evidence and remaining questions. Kidney Int 77:581-587, 2010
54. 2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 69:1431-1437, 2006